LAZARD ASSET MANAGEMENT LLC - HORIZON PHARMA INVT LTD ownership

HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 35 filers reported holding HORIZON PHARMA INVT LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of HORIZON PHARMA INVT LTD
ValueSharesWeighting
Q2 2020$2,012,000
-90.8%
1,040,000
-94.5%
0.00%
-92.5%
Q1 2020$21,945,000
+6.3%
19,000,000
+22.0%
0.04%
+37.9%
Q4 2019$20,653,000
+330.5%
15,580,000
+210.5%
0.03%
+190.0%
Q4 2016$4,797,000
+9.7%
5,017,000
+11.5%
0.01%
+11.1%
Q3 2016$4,373,000
-31.4%
4,500,000
-35.7%
0.01%
-30.8%
Q2 2016$6,378,000
-35.0%
7,000,000
-38.9%
0.01%
-38.1%
Q1 2016$9,811,00011,450,0000.02%
Other shareholders
HORIZON PHARMA INVT LTD shareholders Q4 2019
NameSharesValueWeighting ↓
DW Partners, LP 8,380,000$7,238,0005.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 74,100,000$64,002,0003.41%
SILVERBACK ASSET MANAGEMENT LLC 8,500,000$7,349,0002.78%
Lion Point Capital, LP 16,000,000$13,790,0001.91%
KINGDON CAPITAL MANAGEMENT, L.L.C. 27,250,000$23,486,0001.60%
ADVENT CAPITAL MANAGEMENT /DE/ 54,652,000$47,320,0000.90%
Opera Trading Capital 6,000,000$5,177,0000.90%
LINDEN ADVISORS LP 23,606,000$20,448,0000.86%
Jabre Capital Partners S.A. 8,400,000$7,345,0000.66%
SYMPHONY ASSET MANAGEMENT LLC 5,000,000$4,334,0000.49%
View complete list of HORIZON PHARMA INVT LTD shareholders